Table 1.
Relationship Of High MAGEC2 Expression With Clinicopathological Characteristics In HCC
| Groups | No. | MAGEC2 | χ2 | p Value | |
|---|---|---|---|---|---|
| + | % | ||||
| Gender | |||||
| Male | 85 | 42 | 49.4 | 1.352 | 0.245 |
| Female | 10 | 3 | 30.0 | ||
| Age (years) | |||||
| <60 | 70 | 31 | 44.3 | 1.413 | 0.235 |
| ≥60 | 24 | 14 | 58.3 | ||
| Insufficient data | 1 | 0 | |||
| Tumor size (cm) | |||||
| <5 | 39 | 13 | 33.3 | 5.646 | 0.017* |
| ≥5 | 55 | 32 | 58.2 | ||
| Insufficient data | 1 | 0 | |||
| Pathological grade | |||||
| I-II | 61 | 29 | 47.5 | 0.002 | 0.964 |
| III | 34 | 16 | 47.1 | ||
| T | |||||
| T1 | 12 | 3 | 25.0 | 6.746 | 0.080 |
| T2 | 31 | 12 | 38.7 | ||
| T3 | 41 | 21 | 51.2 | ||
| T4 | 3 | 3 | 100.0 | ||
| Insufficient data | 8 | 6 | |||
| Liver cirrhosis | |||||
| Yes | 36 | 16 | 44.4 | 0.199 | 0.656 |
| No | 59 | 29 | 49.2 | ||
| Gross type | |||||
| Diffuse | 2 | 1 | 50.0 | 7.684 | 0.053 |
| Nodular | 38 | 13 | 34.2 | ||
| Multinodular | 6 | 4 | 66.7 | ||
| Massive | 25 | 17 | 68.0 | ||
| Insufficient data | 24 | 10 | |||
| N | |||||
| N0 | 86 | 38 | 44.2 | 1.245 | 0.264 |
| N1 | 1 | 1 | 100.0 | ||
| Insufficient data | 8 | 6 | |||
| M | |||||
| M0 | 87 | 39 | 44.8 | 1.214 | 0.271 |
| M1 | 1 | 1 | 100.0 | ||
| Insufficient data | 7 | 5 | |||
| TNM stage | |||||
| Stage I | 12 | 3 | 25.0 | 5.807 | 0.121 |
| Stage II | 31 | 12 | 38.7 | ||
| Stage III | 42 | 22 | 52.4 | ||
| Stage IV | 2 | 2 | 100.0 | ||
| Insufficient data | 8 | 6 | |||
| Survival | |||||
| Positive | 34 | 10 | 29.4 | 6.848 | 0.009* |
| Negative | 61 | 35 | 57.4 | ||
Note: *P < 0.05.
Abbreviations: HCC, hepatocellular carcinoma; T, tumor stage; N, node; M, metastasis.